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The RNA-guided DNA endonuclease Cas9 cleaves
double-stranded DNA targets with a protospacer
adjacent motif (PAM) and complementarity to the
guide RNA. Recently, we harnessed Staphylococcus
aureus Cas9 (SaCas9), which is significantly smaller
than Streptococcus pyogenes Cas9 (SpCas9), to
facilitate efficient in vivo genome editing. Here, we
report the crystal structures of SaCas9 in complex
with a single guide RNA (sgRNA) and its double-
stranded DNA targets, containing the 50-TTGAAT-30
PAM and the 50-TTGGGT-30 PAM, at 2.6 and 2.7 A˚
resolutions, respectively. The structures revealed
the mechanism of the relaxed recognition of the
50-NNGRRT-30 PAM by SaCas9. A structural compar-
ison of SaCas9 with SpCas9 highlighted both struc-
tural conservation and divergence, explaining their
distinct PAM specificities and orthologous sgRNA
recognition. Finally, we applied the structural infor-
mation about this minimal Cas9 to rationally design
compact transcriptional activators and inducible nu-
cleases, to further expand theCRISPR-Cas9 genome
editing toolbox.
INTRODUCTION
Advances in our understanding of the CRISPR (clustered regu-
larly interspaced short palindromic repeat)-Cas (CRISPR-asso-
ciated) systems (Mojica et al., 2005; Pourcel et al., 2005; Bolotin
et al., 2005; Makarova et al., 2006; Barrangou et al., 2007;
Brouns et al., 2008; Marraffini and Sontheimer, 2008; Garneau
et al., 2010; Deltcheva et al., 2011; Sapranauskas et al., 2011; Ji-
nek et al., 2012; Gasiunas et al., 2012) have propelled the devel-
opment and applications of Cas9 for genome editing (Cong et al.,
2013;Mali et al., 2013; Cho et al., 2013; Hwang et al., 2013; Jiang
et al., 2013; Jinek et al., 2013). However, much work remains to
understand how Cas9 mediates RNA-guided DNA recognitionand cleavage. Previous studies have shown that Cas9 contains
two endonuclease domains, HNH and RuvC, which cleave the
DNA strands complementary (target DNA strand) and non-com-
plementary (non-target DNA strand) to the guide RNA, respec-
tively (Sapranauskas et al., 2011; Gasiunas et al., 2012; Jinek
et al., 2012), and that Cas9-catalyzed DNA cleavage requires
the presence of a short sequence, known as a protospacer-adja-
cent motif (PAM), located immediately downstream of the target
DNA sequence (Bolotin et al., 2005; Deveau et al., 2008; Mojica
et al., 2009; Garneau et al., 2010; Sapranauskas et al., 2011;
Jinek et al., 2012; Gasiunas et al., 2012). The PAM sequences
are diverse among the orthologous CRISPR-Cas systems, and
the widely used Cas9 from Streptococcus pyogenes (SpCas9)
recognizes a 50-NGG-30 PAM on the non-target DNA strand.
Structural studies of SpCas9 provided insight into the RNA-
guided DNA cleavage mechanism of the Cas9 enzymes. The
crystal structures of SpCas9 in its unbound state (Jinek et al.,
2014), SpCas9 in complex with a single guide RNA (sgRNA)
(Jiang et al., 2015), and SpCas9 in complex with the sgRNA
and its DNA target (Nishimasu et al., 2014; Anders et al., 2014)
revealed that SpCas9 undergoes significant structural rear-
rangement upon association with the sgRNA, and subsequently
adopts a bilobed architecture, consisting of a recognition (REC)
lobe and a nuclease (NUC) lobe, with a central channel envelop-
ing the RNA–DNA heteroduplex (Jinek et al., 2014; Nishimasu
et al., 2014). The PAM is recognized by a PAM-interacting (PI)
domain, which facilitates the target DNA unwinding and the het-
eroduplex formation (Nishimasu et al., 2014; Anders et al., 2014).
In addition to SpCas9, the crystal structure of Actinomyces
naeslundii Cas9 (AnCas9) is also available, but it lacks the
sgRNA and the target DNA (Jinek et al., 2014). Thus, additional
crystal structures of Cas9 orthologs (Chylinski et al., 2013;
Chylinski et al., 2014) bound to nucleic acids are critical to
understand the potential mechanistic and structural conserva-
tions underlying RNA-guided DNA targeting by Cas9, and to
facilitate the development of new Cas9-based genome engi-
neering technologies.
Recently, we harnessed a small Cas9 from Staphylococcus
aureus (SaCas9) for eukaryotic genome editing (Ran et al.,
2015). Although several Cas9 orthologs can cleave DNA targetsCell 162, 1113–1126, August 27, 2015 ª2015 Elsevier Inc. 1113
in vitro, only SaCas9 and SpCas9 exhibit robust activity when
transplanted into mammalian cells. SaCas9 shares only 17%
sequence identity with SpCas9, highlighting the structural and
functional variations among orthologous CRISPR-Cas9 sys-
tems. SaCas9 (1,053 amino acid residues) is significantly smaller
than SpCas9 (1,368 amino acid residues), and thus is easier to
deliver to somatic tissues for genome editing (Ran et al., 2015).
While our previous attempts to create a smaller version of
SpCas9 by rationally removing various domains met with limited
success (Nishimasu et al., 2014), the structure of the naturally
smaller SaCas9 may reveal the minimum and essential compo-
nents of Cas9 enzymes. In addition, SaCas9 recognizes a
50-NNGRRT-30 PAM (where R represents a purine [i.e., A or G]),
which is distinct from the 50-NGG-30 PAM for SpCas9, thereby
offering an opportunity to understand the diverse PAM specific-
ities of the Cas9 orthologs.
Here, we report the crystal structures of SaCas9 in complex
with the sgRNA and its target DNA, containing either the
50-TTGAAT-30 PAM (2.6 A˚ resolution) or the 50-TTGGGT-30
PAM (2.7 A˚ resolution), to facilitate a comparative analysis of
the distinct Cas9 orthologs and to provide the structural founda-
tion for the rational design of SaCas9-based genome engineer-
ing tools. Our structural and functional data provide insight into
the PAM-dependent, RNA-guided DNA cleavage mechanism
of SaCas9, as well as the minimal requirements for general
Cas9 activity. Furthermore, our data enable the structural com-
parison between SaCas9 and SpCas9, revealing notable differ-
ences in the interactions in their REC lobe–sgRNA scaffolds
and PI domain–PAM sequences. These comparative results
also highlighted the flexible nature of the RuvC and HNH
nuclease domains, and identified a previously uncharacterized
and evolutionarily divergent wedge (WED) domain. Given its
compact size, SaCas9 holds great potential as a minimum scaf-
fold for genome engineering. The structural and comparative
data presented here advance our understanding of the RNA-
guided DNA cleavage mechanism and provide a starting point
for the future design of Cas9 variants with expanded target
space and improved specificity.
RESULTS
Overall Structure of the SaCas9–sgRNA–Target DNA
Complex
We solved the crystal structures of full-length SaCas9 (residues
1–1053; N580A/C946A) in complex with a 73-nucleotide (nt)
sgRNA, a 28-nt target DNA strand and an 8-nt non-target
DNA strand, containing either the 50-TTGAAT-30 PAM or 50-
TTGGGT-30 PAM, at 2.6 and 2.7 A˚ resolutions, respectively (Fig-
ures 1A–1D, Figure S1A, and Table S1). Since solvent-exposed
cysteine residues may hamper crystallization, we replaced a
non-conserved cysteine residue (Cys946) with alanine after con-
firming that the C946A mutation did not affect the DNA cleavage
activity in vivo (Figures S1B–S1D). Based on homology to
SpCas9, we mutated one of the putative catalytic residues,
Asn580 in the HNH domain, to alanine to prevent the potential
cleavage of the target DNA during crystallization. Since the two
structures are virtually identical (root-mean-square deviation
[rmsd] of 0.2 A˚ for 1,043 equivalent Ca atoms), we will describe1114 Cell 162, 1113–1126, August 27, 2015 ª2015 Elsevier Inc.the quaternary complex structure containing the 50-TTGAAT-30
PAM unless otherwise stated.
SaCas9 adopts a bilobed architecture consisting of a REC
lobe (residues 41–425) and a NUC lobe (residues 1–40 and
435–1053) (Figures 1C and 1D). The two lobes are connected
by an arginine-rich bridge helix (residues 41–73) and a linker
loop (residues 426–434). The NUC lobe consists of the RuvC
(residues 1–40, 435–480 and 650–774), HNH (residues 520–
628), WED (residues 788–909), and PI (residues 910–1053) do-
mains (Figures 1C and 1D). The PI domain can be divided into
a Topoisomerase-homology (TOPO) domain and a C-terminal
domain, as in SpCas9 (Jinek et al., 2014). The RuvC domain con-
sists of three separate motifs (RuvC-I–III) and interacts with the
HNH and PI domains. The HNH domain is connected to RuvC-
II and RuvC-III by the L1 (residues 481–519) and L2 (residues
629–649) linker regions, respectively. The WED and RuvC do-
mains are connected by a ‘‘phosphate lock’’ loop (residues
775–787), as in SpCas9 (Anders et al., 2014). The active site of
the HNH domain is distant from the cleavage site in the target
DNA strand (the phosphodiester linkage between dC3 and
dA4), indicating that the present structure represents the inactive
state, as in the cases of the SpCas9–sgRNA–target DNA com-
plex structures (Nishimasu et al., 2014; Anders et al., 2014).
Previous structural studies revealed that SpCas9 undergoes
conformational rearrangements upon guide RNA binding, to
form the central channel between the REC and NUC lobes (Jinek
et al., 2014; Nishimasu et al., 2014; Anders et al., 2014; Jiang
et al., 2015). In the absence of the guide RNA, SpCas9 and
AnCas9 adopt a closed conformation, where the active site of
the HNH domain is covered by the RuvC domain (Figure S2). In
contrast, the ternary and quaternary complex structures of
SpCas9 adopt an open conformation and have the central chan-
nel, which accommodates the guide RNA–target DNA heterodu-
plex (referred to as the guide:target heteroduplex) (Figures 1E
and 1F). The present quaternary complex structure of SaCas9
adopts a similar open conformation to form the central channel,
which accommodates the guide:target heteroduplex (Figures 1C
and 1D), suggesting that the guide RNA-induced conformational
activation is conserved between SaCas9 and SpCas9. A struc-
tural comparison between SaCas9 and SpCas9 revealed that,
although their overall architectures are similar, there are notable
differences in their REC, WED, and PI domains, as described in
detail below, thereby explaining the significant sequence and
size differences of the two Cas9 orthologs (Figures 1C–1F and
Figure S3).
Structure of the sgRNA–Target DNA Complex
The SaCas9 sgRNA consists of the guide region (G1–C20),
repeat region (G21–G34), tetraloop (G35–A38), anti-repeat re-
gion (C39–C54), stem loop 1 (A56–G68), and single-stranded
linker (U69–U73), with A55 connecting the anti-repeat region
and stem loop 1 (Figures 2A–2D). U73 at the 30 end is disordered
in the present structure. The guide region (G1–C20) and the
target DNA strand (dG1–dC20) form the guide:target heterodu-
plex, whereas the target DNA strand (dC(8)–dA(1)) and the
non-target DNA strand (dT1*–dG8*) form a PAM-containing
duplex (referred to as the PAM duplex) (Figures 2A and 2B).
The repeat (G21–G34) and anti-repeat (C39–C54) regions form
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Figure 1. Structure of the SaCas9–sgRNA–Target DNA Complex
(A) Domain organization of SaCas9. BH, bridge helix; CTD, C-terminal domain.
(B) Schematic of the sgRNA–target DNA complex. The putative stem loop 2 was truncated for crystallization.
(C and D) Ribbon (C) and surface (D) representations of the SaCas9–sgRNA–target DNA complex. The active sites of the RuvC (Asp10) and HNH (Asn580)
domains are indicated by red circles. Molecular graphics images were prepared using CueMol (http://www.cuemol.org).
(E and F) Ribbon (E) and surface (F) representations of the SpCas9–sgRNA–target DNA complex (PDB: 4UN3). The SpCas9-specific insertions in the REC and PI
domains are highlighted in pale blue. In (F), the L1 and L2 linker regions and the HNH domain are omitted for clarity.
See also Figures S1, S2, and S3.
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Figure 2. Structure of the sgRNA–Target DNA Complex
(A) Nucleotide sequences of the sgRNA and the target DNA. The putative stem loop 2 (dashed box) was truncated for crystallization. U73 is disordered in the
structure.
(B) Overview of the sgRNA–target DNA complex.
(C and D) Close-up views of the repeat:anti-repeat duplex (C) and stem loop 1 (D). Key interactions are shown as dashed lines.
(legend continued on next page)
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a distorted duplex (referred to as the repeat:anti-repeat duplex)
via 13 Watson-Crick base pairs (Figures 2A and 2B). The un-
paired nucleotides (C30, A43, U44, and C45) form an internal
loop (Figure 2C). This distorted structure of the repeat:anti-
repeat duplex is precisely recognized by the REC and WED
domains, as the insertion of GAU into the repeat region, which
eliminated the internal loop, drastically reduced the Cas9-medi-
ated DNA cleavage (Figure 2E).
Stem loop 1 is formed via three Watson-Crick base pairs
(G57:C67–C59:G65) and two non-canonical base pairs (A56:
G68 and A60:A63) (Figures 2A and 2D). U64 does not base
pair with A60 and is flipped out of the stem loop (Figure 2D).
The N1 and N6 of A63 hydrogen bond with the 20-OH and N3
of A60, respectively. G68 stacks with G57:C67, with the G68
N2 interacting with the backbone phosphate group between
A55 and A56. A55 adopts the syn conformation, and its adenine
base stacks with U69 (Figure 2D). In addition, the N1 of A55
hydrogen bonds with the 20-OH of G68, thus stabilizing the
basal region of stem loop 1. An adenosine residue immediately
after the repeat:anti-repeat duplex is highly conserved among
CRISPR-Cas9 systems, and the equivalent adenosine in the
SpCas9 sgRNA, A51, also adopts the syn conformation (Nishi-
masu et al., 2014; Anders et al., 2014) (Figure S4A), suggesting
that these adenosine residues play conserved key roles in con-
necting the repeat:anti-repeat duplex and stem loop 1.
The SpCas9 sgRNA contains three stem loops (stem loops
1–3), which interact with Cas9 and contribute to complex forma-
tion (Nishimasu et al., 2014) (Figure 2F and Figure S4A). The
sgRNA lacking stem loops 2 and 3 supports SpCas9-catalyzed
DNA cleavage in vitro but not in vivo, indicating the importance
of stem loops 2 and 3 for the cleavage activity in vivo (Cong
et al., 2013; Hsu et al., 2013; Nishimasu et al., 2014; Wright
et al., 2015). In contrast, the SaCas9 sgRNA is predicted to
contain only two stem loops (stem loops 1 and 2), based on its
nucleotide sequence (Figure S4B). As in SpCas9, the sgRNA
lacking stem loop 2 supported SaCas9-catalyzed DNA cleavage
in vitro but not in vivo (Figure 2E and Figure S4C), suggesting that
the secondary structures on the 30 tracrRNA tail of the sgRNA are
critical for successfully harnessing Cas9 for genome editing
applications. Although we failed to obtain diffraction-quality
crystals of SaCas9 bound to a version of sgRNA containing the
full-length tracrRNA, the truncation of stem loop 2 dramatically
improved the quality of the crystals. Thus, it remains unknown
how stem loop 2 interacts with SaCas9, although it may bind
to the positively charged groove between the RuvC and PI do-
mains, as in SpCas9 (Nishimasu et al., 2014; Anders et al.,
2014) (Figure 1D and Figure S4D).
Recognition Mechanism of the Guide:Target
Heteroduplex
The guide:target heteroduplex is accommodated in the central
channel formed between the REC and NUC lobes (Figures 1D
and 3). The sugar-phosphate backbone of the PAM-distal region(E) Mutational analysis of SaCas9 sgRNA scaffolds. Effects of mutations on the a
from the sgRNA (+77) scaffold are shown at the respective positions, with dashe
(F) Superimposition of the sgRNAs of SaCas9 and SpCas9 (PDB: 4OO8) (stereov
See also Figure S4.(A3–U6) of the sgRNA interacts with the REC lobe (Thr238,
Tyr239, Lys248, Tyr256, Arg314, Asn394, and Gln414) (Figure 3).
In SpCas9 and SaCas9, the RNA–DNA base pairing in the 8 bp
PAM-proximal ‘‘seed’’ region in the guide:target heteroduplex
is critical for Cas9-catalyzed DNA cleavage (Jinek et al., 2012;
Hsu et al., 2013; Ran et al., 2015). Consistent with this, the phos-
phate backbone of the sgRNA seed region (C13–C20) is exten-
sively recognized by the bridge helix (Asn44, Arg48, Arg51,
Arg55, Arg59, and Arg60) and the REC lobe (Arg116, Gly117,
Arg165, Gly166, Asn169, and Arg209) (Figures 3 and 4A), as in
the case of SpCas9 (Nishimasu et al., 2014). In addition, the
20-OH groups of C15, U16, U17, and G19 interact with the REC
lobe (Gly166, Arg208, Arg209, and Tyr211). These structural
findings suggest that the sgRNA binds to SaCas9 with its seed
region pre-ordered in an A-form conformation for base-pairing
with the target DNA strand, as observed in the SpCas9–sgRNA
binary complex (Jiang et al., 2015). In addition, the sugar-phos-
phate backbone of the target DNA strand interacts with the REC
lobe (Tyr211, Trp229, Tyr230, Gly235, Arg245, Gly391, Thr392,
and Asn419) and the RuvC domain (Leu446, Tyr651 and
Arg654) (Figure 3). These structural observations explain the
RNA-guided DNA targeting mechanism of SaCas9.
The C-terminal region of the REC lobe interacts with the PAM-
distal region of the heteroduplex, whereas the N-terminal region
of the REC lobe interacts with the repeat:anti-repeat duplex and
the PAM-proximal region of the heteroduplex (Figure 3). Notably,
the C-terminal region of the REC lobe of SaCas9 shares struc-
tural similarity with those of SpCas9 (PDB: 4UN3, 26% identity,
rmsd of 1.9 A˚ for 177 equivalent Ca atoms) and AnCas9 (PDB:
4OGE, 16% identity, rmsd of 3.2 A˚ for 167 equivalent Ca atoms)
(Figure S5). These structural findings suggested that the Cas9
orthologs recognize the PAM-distal region of the guide:target
heteroduplex in a similar manner.
Recognition Mechanism of the sgRNA Scaffold
The repeat:anti-repeat duplex is recognizedby theRECandWED
domains, primarily through interactions between the protein and
the sugar-phosphate backbone (Figures 3 and 4B). Consistent
with our data showing that the distorted repeat:anti-repeat
duplex is critical for Cas9-catalyzed DNA cleavage (Figure 2E),
the internal loop is recognized by the WED domain (Figure 4B).
The 20-OH of C30 hydrogen bonds with Tyr868, and the back-
bone phosphate groups of U31, C45, and U46 interact with
Lys870, Arg792, and Lys881, respectively (Figure 4B). These
structural observations explain the structure-dependent recogni-
tion of the repeat:anti-repeat duplex by SaCas9.
Stem loop 1 is recognized by the bridge helix and the REC lobe
(Figures 3 and 4C). The phosphate backbone of stem loop 1 in-
teracts with the bridge helix (Arg47, Arg54, Arg55, Arg58, and
Arg59) and the REC lobe (Arg209, Gly216, and Ser219) (Fig-
ure 4C). The 20-OH of A63 hydrogen bonds with His62. The
flipped-out U64 is recognized by Arg209 and Glu213 via
stacking and hydrogen-bonding interactions, respectively. A55bility to induce indels in the target EMX1 locus were examined. Base changes
s indicating unaltered bases (n = 3, error bars show mean ± SEM).
iew).
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Figure 3. Schematic of Nucleic Acid Recog-
nition by SaCas9
SaCas9 residues that interact with the sgRNA and
the target DNA via their main chain are shown in
parentheses. Water-mediated hydrogen-bonding
interactions are omitted for clarity.is extensively recognized by the phosphate lock loop (Figure 4D).
The N6, N7, and 20-OH of A55 hydrogen bond with Asn780/
Arg781, Leu783, and Lys906, respectively. Lys57 interacts with
the backbone phosphate group between C54 and A55, and
the side chain of Leu783 forms hydrophobic contacts with the
nucleobases of A55 and A56. The phosphate backbone of the
linker region electrostatically interacts with the RuvC domain
(Arg452, Lys459, and Arg774) and the phosphate lock loop
(Arg781), and the nucleobase of G70 stacks with the side chain
of Arg47 on the bridge helix (Figure 4D).
Structural Basis for the Orthogonal Recognition of
sgRNA Scaffolds
A comparison of the quaternary complex structures of SaCas9
and SpCas9 revealed that the structurally diverse REC and1118 Cell 162, 1113–1126, August 27, 2015 ª2015 Elsevier Inc.WED domains recognize distinct struc-
tural features of the repeat:anti-repeat
duplex, allowing the cognate sgRNAs to
be distinguished in a highly specific
manner (Figures 4E and 4F and Fig-
ure S6). The SaCas9 WED domain has a
new fold comprising a twisted five-
stranded b sheet flanked by four a
helices, and is responsible for the recog-
nition of the distorted repeat:anti-repeat
duplex, as described above (Figures 4B
and 4E and Figures S6A and S6B). In
contrast, the SpCas9 WED domain
adopts a compact loop conformation
and interacts with the repeat:anti-repeat
duplex, which is structurally different
from that of the SaCas9 sgRNA (Nishi-
masu et al., 2014; Anders et al., 2014)
(Figure 4F and Figures S6A and S6C).
The AnCas9 WED domain has yet
another different fold containing three
antiparallel b-hairpins (Jinek et al., 2014)
(Figure S6A). These structural differences
in the WED domains are consistent with
the variations in the sgRNA scaffolds
among the CRISPR-Cas9 systems (Fon-
fara et al., 2014; Briner et al., 2014; Ran
et al., 2015).
The REC lobes also contribute to the
orthogonal recognition of the sgRNA
scaffolds. While the REC lobes of
SaCas9 and SpCas9 share structural
similarity, the SpCas9 REC lobe has
four characteristic insertions (Ins 1–4),
which are absent in the SaCas9 REClobe (Figures 4E and 4F and Figures S6B and S6C). Ins 2 (also
known as the REC2 domain) does not contact the nucleic acids
in the SpCas9 structures and is dispensable for the DNA cleav-
age activity (Nishimasu et al., 2014), consistent with the absence
of Ins 2 in SaCas9 (Figures 4E and 4F). Ins 1 and 3 recognize the
SpCas9-specific internal loop in the repeat:anti-repeat duplex
(Figure 4F and Figure S6C). In particular, Ins 3 interacts with
the flipped-out G43 and U44 in the repeat:anti-repeat duplex in
base-specific manners (Figure S6C). In addition, Ins 4 interacts
with stem loop 1 of the SpCas9 sgRNA, which is shorter than
that of the SaCas9 sgRNA (Figures 4E and 4F and Figures S6B
and S6C). Together, these structural observations demonstrate
how the Cas9 orthologs recognize their cognate sgRNAs in
orthogonal manners, using specific combinations of the structur-
ally diverse REC and WED domains.
Recognition Mechanism of the 50-NNGRRT-30 PAM
SaCas9 recognizes the 50-NNGRRN-30 PAM, with a preference
for a thymine base at the 6th position (Ran et al., 2015), which
is distinct from the 50-NGG-30 PAM of SpCas9. In the present
structures containing either the 50-TTGAAT-30 PAM or the
50-TTGGGT-30 PAM, the PAM duplex is sandwiched between
the WED and PI domains, and the PAM in the non-target DNA
strand is read from the major groove side by the PI domain (Fig-
ures 5A and 5B). dT1* and dT2* do not directly contact the
protein (Figures 5A and 5B). Consistent with the observed
requirement for the 3rd G in the 50-NNGRRT-30 PAM, the O6
and N7 of dG3* form bidentate hydrogen bonds with the side
chain of Arg1015, which is anchored via salt bridges with
Glu993 in both complexes (Figures 5A and 5B). In the
50-TTGAAT-30 PAM complex, the N7 atoms of dA4* and dA5*
form direct and water-mediated hydrogen bonds with Asn985
and Asn985/Asn986/Arg991, respectively (Figure 5A). In addi-
tion, the N6 of dA5* forms a water-mediated hydrogen bond
with Asn985. Similarly, in the 50-TTGGGT-30 PAM complex, the
N7 atoms of dG4* and dG5* form direct and water-mediated
hydrogen bonds with Asn985 and Asn985/Asn986/Arg991,
respectively (Figure 5B). The O6 of dG5* forms a water-mediated
hydrogen bond with Asn985. These structural features explain
the ability of SaCas9 to recognize the purine nucleotides at po-
sitions 4 and 5 in the 50-NNGRRT-30 PAM. The O4 of dT6*
hydrogen bonds with Arg991 (Figures 5A and 5B), explaining
the preference of SaCas9 for the 6th T in the 50-NNGRRT-30
PAM. Single alanine mutations of these PAM-interacting resi-
dues reduced the cleavage activity in vivo, and doublemutations
abolished the activity (Figure 5C), confirming the importance of
Asn985, Asn986, Arg991, Glu993, and Arg1015 for PAM recog-
nition. In addition, the phosphate backbone of the PAM duplex
is recognized from the minor groove side by the WED domain
(Tyr789, Tyr882, Lys886, Ans888, Ala889, and Leu909), in a
distinct manner from that in SpCas9 (Figure 3). Together, our
structural and functional data have revealed the mechanism un-
derlying the relaxed recognition of the 50-NNGRRT-30 PAM by
SaCas9.
Structural Basis for the Distinct PAM Specificities
A structural comparison of SaCas9, SpCas9, and AnCas9 re-
vealed that, despite the lack of sequence homology, their PI
domains share a similar protein fold (Figures 5D and 5E, and
Figure S6A). The PI domains consist of the TOPO domain,
comprising a three-stranded anti-parallel b sheet (b1–b3) flanked
by several a helices, and the C-terminal domain, comprising a
twisted six-stranded anti-parallel b sheet (b4–b9) (b7 in SpCas9
adopts a loop conformation) (Figures 5D and 5E and Figure S6A).
In both SaCas9 and SpCas9, the major groove of the PAM
duplex is read by the b5–b7 region in their PI domains (Figures
5D and 5E). The 3rd G in the 50-NNGRRT PAM-30 is recognized
by Arg1015 in SaCas9 (Figure 5D), whereas the 3rd G in the
50-NGG-30 PAM is recognized by Arg1335 in SpCas9 in a similar
manner (Figure 5E). However, there are notable differences in the
PI domains of SaCas9 and SpCas9, consistent with their distinct
PAM specificities. Arg1333 of SpCas9, which recognizes the 2nd
G in the 50-NGG-30 PAM, is replaced with Pro1013 in SaCas9
(Figures 5D and 5E and Figure S3). In addition, SpCas9 lacksthe amino acid residues equivalent to Asn985/Asn986 (b5) and
Arg991 (b6) of SaCas9, because the b5–b6 region of SpCas9 is
shorter than that of SaCas9 (Figures 5D and 5E and Figure S3).
Moreover, Asn985, Asn986, Arg991, and Arg1015 in SaCas9
are replaced with Asp1030, Thr1031, Lys1034, and Lys1061 in
AnCas9, respectively (Figure S6A), suggesting that the PAM of
AnCas9 is different from those of SaCas9 and SpCas9 (although
the sequence remains unknown). Together, these structural find-
ings demonstrate that the distinct PAM specificities of the Cas9
orthologs are primarily defined by the specific differences in the
PAM-interacting residues in the PI domains.
Mechanism of Target DNA Unwinding
In SpCas9, Glu1108 and Ser1109, in the phosphate lock loop,
hydrogen bond with the phosphate group between dA(1) and
dT1 in the target DNA strand (referred to as the +1 phosphate),
thereby contributing to the target DNA unwinding (Anders
et al., 2014) (Figure 5F). The present structure revealed that
SaCas9 also has the phosphate lock loop, although it shares
limited sequence similarity to that of SpCas9 (Figure 5G and Fig-
ure S3). In SaCas9, the +1 phosphate between dA(1) and dG1,
in the target DNA strand, hydrogen bonds with the main-chain
amide groups of Asp786 and Thr787 and the side chain of
Thr787 in the phosphate lock loop (Figure 5G). These interac-
tions result in the rotation of the +1 phosphate, thereby facili-
tating base-pairing between dG1 in the target DNA strand and
C20 in the sgRNA. Indeed, the SaCas9 T787A mutant showed
reduced DNA cleavage activity (Figure 5C), confirming the func-
tional significance of Thr787 in the phosphate lock loop. These
observations indicated the conserved molecular mechanism of
target DNA unwinding in SaCas9 and SpCas9.
RuvC and HNH Nuclease Domains
The RuvC domain of SaCas9 has an RNase H fold, and shares
structural similarity with those of SpCas9 (PDB: 4UN3, 26%
identity, rmsd of 2.0 A˚ for 179 equivalent Ca atoms) and AnCas9
(PDB: 4OGE, 17% identity, rmsd of 3.0 A˚ for 169 equivalent Ca
atoms) (Figure 6A). Asp10, Glu477, His701, and Asp704 of
SaCas9 are located at positions similar to those of the catalytic
residues of SpCas9 (Asp10, Glu762, His983, and Asp986) and
AnCas9 (Asp17, Glu505, His736, and Asp739) (Figure 6A and
Figure S3). Indeed, the D10A, E477A, H701A, and D704A mu-
tants of SaCas9 exhibited almost no DNA cleavage activity (Fig-
ures S7A and S7B), suggesting that the SaCas9 RuvC domain
cleaves the non-target DNA strand through a two-metal ion
mechanism, as in other RNase H superfamily endonucleases
(Go´recka et al., 2013).
The HNH domain of SaCas9 has a bba-metal fold, and shares
structural similarity with those of SpCas9 (27% identity, rmsd of
1.8 A˚ for 93 equivalent Ca atoms) and AnCas9 (18% identity,
rmsd of 2.6 A˚ for 98 equivalent Ca atoms) (Figure 6B). Asp556,
His557, and Asn580 of SaCas9 are located at positions similar
to those of the catalytic residues of SpCas9 (Asp839, His840,
and Asn863) and AnCas9 (Asp581, His582, and Asn606) (Fig-
ure 6B and Figure S3). Indeed, the H557A and N580A mutants
of SaCas9 almost completely lacked DNA cleavage activity
(Figures S7A and S7B), suggesting that the SaCas9 HNH
domain cleaves the target DNA strand through a one-metal ionCell 162, 1113–1126, August 27, 2015 ª2015 Elsevier Inc. 1119
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mechanism, as in other bba-metal endonucleases (Biertu¨mpfel
et al., 2007).
A structural comparison of SaCas9 with SpCas9 and AnCas9
revealed that the RuvC and HNH domains are connected by
a-helical linkers, L1 and L2, and that notable differences exist
in the relative arrangements between the two nuclease domains
(Figure 6C). A biochemical study suggested that PAM duplex
binding to SpCas9 facilitates the cleavage of the target DNA
strand by the HNH domain (Sternberg et al., 2014). However,
in the PAM-containing quaternary complex structures of SaCas9
andSpCas9, the HNHdomains are distant from the cleavage site
of the target DNA strand (Figure 6C). A structural comparison of
SaCas9 with Thermus thermophilus RuvC in complex with a
Holliday junction substrate (Go´recka et al., 2013) indicated steric
clashes between the L1 linker and the modeled non-target DNA
strand, bound to the active site of the SaCas9 RuvC domain
(Figures S7C and S7D). These observations suggested that the
binding of the non-target DNA strand to the RuvC domain may
facilitate a conformational change of L1, thereby bringing the
HNH domain to the scissile phosphate group in the target DNA
strand.
Structure-Guided Engineering of SaCas9 Transcription
Activators and Inducible Nucleases
Using the crystal structure of SaCas9, we sought to conduct
structure-guided engineering to further expand the CRISPR-
Cas9 toolbox, as we have done previously using the SpCas9
crystal structure. Given the similarities in the overall domain
organizations of SaCas9 and SpCas9, we initially explored the
feasibility of engineering the SaCas9 sgRNA, to develop robust
transcription activators. In the SpCas9 structure, the tetraloop
and stem loop 2 of the sgRNA are exposed to the solvent (Nishi-
masu et al., 2014; Anders et al., 2014) (Figure S4D), and
permitted the insertion of RNA aptamers into the sgRNA to
create robust RNA-guided transcription activators (Konermann
et al., 2015). To generate the SaCas9-based activator system,
we created a catalytically inactive version of SaCas9 (dSaCas9)
by introducing the D10A and N580A mutations to inactivate the
RuvC and HNH domains, respectively, and attached VP64 to
theC terminus of dSaCas9 (Figures 7A and 7B). The sgRNA scaf-
fold was modified by the insertion of the MS2 aptamer stem loop
(MS2-SL), to allow the recruitment of MS2-p65-HSF1 transcrip-
tional activation modules (Figure 7A). To evaluate the dSaCas9-
based activator design, we constructed a transcriptional
activation reporter system, consisting of tandem sgRNA target
sites upstream of a minimal CMV promoter driving the expres-
sion of the fluorescent reporter gene mKate2 (Zhang et al.,
2011) (Figure 7B). We included an additional transcriptional
termination signal upstream of the reporter cassette, to reduce
the background previously observed in a similar reporter (Cong
et al., 2012) (Figure 7B). We observed robust activation ofFigure 4. sgRNA Recognition Mechanism
(A–D) Recognition of the seed region (A), the repeat:anti-repeat duplex (B), stem
bridges are shown as dashed lines. In (A), the target DNA strand is omitted for c
(E and F) Recognition of the sgRNA and target DNA by the REC andWEDdomains
highlighted in pale blue.
See also Figures S5 and S6.mKate2 transcription whenwe expressed the engineered sgRNA
complementary to the target sites, whereas the non-binding
sgRNA had no detectable effect (Figure 7C). Based on a
screening of different sgRNA designs with this reporter assay,
we found that the insertions of MS2-SL into the tetraloop and
putative stem loop 2 induced strong activation in our reporter
system, whereas the insertion of MS2-SL into stem loop 1
yielded modest activation, consistent with the structural data
(Figure 7D). The single insertion of MS2-SL into the tetraloop
was the simplest design that yielded strong transcriptional acti-
vation. Using this optimal sgRNA design, we further tested the
activation of endogenous targets in the human genome. We
selected two guides each for the human ASCL1 and MYOD1
genomic loci, and demonstrated that the dSaCas9-based acti-
vator system activated both genes to levels comparable to
those of the dSpCas9-based activator (Konermann et al.,
2013) (Figure 7E). Given that the sgRNAs for SaCas9 and
SpCas9 are not interchangeable, the SaCas9-based transcrip-
tion activator platform complements the SpCas9-based acti-
vator systems, by allowing the independent activation of
different sets of genes.
The SpCas9 structure also facilitated the rational design of
split-Cas9s (Zetsche et al., 2015; Wright et al., 2015), which
can be further engineered into an inducible system (Zetsche
et al., 2015). Our SaCas9 structure revealed several flexible re-
gions in SaCas9 that could likewise serve as potential split sites
(Figure 7F).We created three versions of a split-SaCas9, and two
of them showed robust cleavage activity at the endogenous
EMX1 target locus (Figure 7G). Using the best split design, we
then tested inducible schemes based on the abscisic acid
(ABA) sensing system (Liang et al., 2011), as well as two versions
of the rapamycin-inducible FKBP/FRB system (Banaszynski
et al., 2005) (Figures 7H and 7I). All three systems were able to
support inducible SaCas9 cleavage activity, demonstrating the
possibility of an inducible, split-SaCas9 design; however, further
optimization is required to increase its efficiency and reduce its
background activity (Figure 7J).
DISCUSSION
The present SaCas9 complex structures allow a detailed struc-
tural comparison of Cas9 orthologs bound to nucleic acids,
thereby illuminating the conserved structural features. SaCas9
and SpCas9 both adopt a bilobed architecture consisting of
the REC and NUC lobes, with the guide:target heteroduplex
accommodated between these lobes. In addition, both Cas9 or-
thologs have a phosphate lock loop, which participates in target
DNA unwinding and heteroduplex formation. We also found that
the HNH and RuvC domains are connected by the L1 and L2
linkers in both SaCas9 and SpCas9. These flexible linker regions
appear to play a role in the inactive-to-active conformationalloop 1 (C), and the basal region of stem loop 1 (D). Hydrogen bonds and salt
larity.
of SaCas9 (E) and SpCas9 (PDB: 4UN3) (F). The SpCas9-specific insertions are
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Figure 5. PAM Recognition Mechanism
(A and B) Recognition of the 50-TTGAAT-30 PAM (A) and the 50-TTGGGT-30 PAM (B) (stereoview). The PAM sequences are highlighted in purple. Water molecules
are shown as red spheres. Hydrogen bonds are shown as dashed lines.
(C) Mutational analysis of the PAM-interacting residues and the phosphate lock loop (PLL), measured by indel rates at two EMX1 targets (n = 3, error bars show
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See also Figure S6.
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See also Figure S7.transition of the HNH domain, although further structural and
functional studies are required to elucidate the activation mech-
anism of Cas9 enzymes.
A comparison of the Cas9 orthologs also revealed the struc-
tural diversity among the CRISPR-Cas9 systems. In both
SaCas9 and SpCas9, the structurally diverse REC and WED do-
mains are responsible for the recognition of sgRNA scaffolds,
which have diverse sequences and structures among the
CRISPR-Cas9 systems, thereby enabling the orthogonal, spe-
cies-specific recognition of the sgRNA scaffolds. In addition,
the PI domains of SaCas9, SpCas9, and AnCas9 share a similarcore fold, but possess different PAM-interacting residues, corre-
sponding to their distinct PAM specificities.
We leveraged our newly obtained structural knowledge to
develop SaCas9-based transcriptional activators and inducible
SaCas9 systems. This opens the door to new possibilities,
including the combinatorial use of SaCas9- and SpCas9-based
genome editing and transcriptional regulation systems, to enable
simultaneous, inducible editing, activation or repression of mul-
tiple endogenous loci. Further applications include the design of
a minimal Cas9 enzyme with tailored PAM specificities as well as
increased specificity for more versatile genome editing.Cell 162, 1113–1126, August 27, 2015 ª2015 Elsevier Inc. 1123
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EXPERIMENTAL PROCEDURES
Detailed experimental procedures are described in the Supplemental Experi-
mental Procedures.
The full-length S. aureus Cas9 N580A/C946A mutant (residues 1–1053) was
expressed inEscherichia coliRosetta 2 (DE3) (Novagen) and purifiedby chroma-
tography on Ni-NTA Superflow (QIAGEN), Mono S (GE Healthcare), and HiLoad
Superdex 200 16/60 (GE Healthcare) columns. The SeMet-labeled protein was
expressed in E. coli B834 (DE3) (Novagen) and purified using a similar protocol
as that for the native protein. The sgRNAwas transcribed in vitrowithT7RNApo-
lymerase and purified by 8%denaturing (7M urea) PAGE. The target DNAswere
purchased from Sigma-Aldrich. The purified SaCas9 protein wasmixed with the
sgRNA, targetDNAstrand,andnon-targetDNAstrand (molar ratio, 1:1.5:2.3:3.4),
and the SaCas9–sgRNA–target DNA complex was purified by gel filtration
chromatography on a Superdex 200 Increase column (GE Healthcare).
The purified SaCas9–sgRNA–target DNA complex (containing either the
50-TTGAAT-30 PAM or the 50-TTGGGT-30 PAM) was crystallized at 20C by
the hanging-drop vapor diffusion method. Crystals were obtained by mixing
1 ml of the complex solution (A260 nm, 15) and 1 ml of the reservoir solution
(10%–12% PEG 4,000, 0.75 M NaCl, 0.15 M Na2HPO4 and 0.15 M NaN3).
The SeMet-labeled complex (containing the 50-TTGGGT-30 PAM) was crystal-
lized under similar conditions. X-ray diffraction data were collected at 100 K on
the beamlines BL32XU and BL41XU at SPring-8 (Hyogo, Japan). The structure
was determined by the Se-SAD method, using the 3 A˚ resolution dataset from
the SeMet-labeled crystal. The final models of the 50-TTGAAT-30 PAMcomplex
(2.6 A˚ resolution) and the 50-TTGGGT-30 PAM complex (2.7 A˚ resolution) were
refined using the native datasets. Molecular graphics images were prepared
using CueMol (http://www.cuemol.org).
Around 24 hr prior to transfection, HEK293FT cells (Life Technologies) were
seeded into 24-well plates (Corning) at a density of 2.5 3 105 cells/well and
transfected at 70%–80% confluency using Lipofectamine 2000 (Life Technol-
ogies), according to the manufacturer’s recommended protocol. A total of
600 ngDNAwas used for eachwell of the 24-well plate. About 72 hr after trans-
fection, the genomic DNA was extracted, and then the genomic modifications
were examined using the SURVEYOR assay and targeted deep sequencing,
as previously described (Cong et al., 2013).
ACCESSION NUMBERS
The accession numbers for the atomic coordinates of the SaCas9–sgRNA–
target DNA complexes reported in this paper are Protein Data Bank: 5CZZ
(50-TTGAAT-30 PAM) and 5AXW (50-TTGGGT-30 PAM).
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